Sat. Aug 13th, 2022
GlaxoSmithKline Pharma Q2 net profit declines 85% to Rs 76.47 crore The company has recognised a financial impact of Rs 64.13 crore for the latest September quarter mainly to reflect the estimated realisable value of the assets, associated costs and impacts of reversal of provision on account of Zinetac recall, the filing said.